About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNCT01276483

Treatment Response Evaluation in Gastrointestinal Stromal Tumor (GIST) Patients

The purpose of this study is to compare sensitivity, specificity and accuracy of PET, DW MRI and CT separately and combined for the evaluation of treatment response and progression-free survival in pa...

Lead sponsor: Oslo University Hospital•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Oslo University Hospital

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Metastatic GIST patients suitable for TKI treatment
•GIST patients pursuing preoperative neoadjuvant TKI treatment

Exclusion Criteria

•Patients with contraindications to MRI and/or TKI treatment. For patients with renal failure, CT without intravenous contrast will be performed according to clinical practice.
•Patients who do not sign the consent paper for any reason or do not accept the study premises or patients who wish to withdraw for any reason during the study

Related studies

Acquisition of Blood and Tumor Tissue Samples From Patients With Gastrointestinal Cancer

NCT01313442 · Non-GI Cancers, Cancer of Gastrointestinal Tract, and more

Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes

NCT04907643 · Cancer Pain, Visceral Pain, and more

RECRUITINGPhase 2

Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection

NCT07293910 · HELICOBACTER PYLORI INFECTIONS, Helicobacter Infection, and more

RECRUITINGPhase 2

JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas

NCT06716658 · Lymphoma, T-Cell, NK-LGL Leukemia, and more

A Registry for People With T-cell Lymphoma

NCT05978141 · T-cell Lymphoma, NK-Cell Lymphoma, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 22, 2017Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment40

Start dateFeb 2011

Last updatedJun 22, 2017

Condition

Soft Tissue Neoplasms Gastrointestinal Tract

Locations shown

Oslo University Hosptal

Oslo

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 22, 2017Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions